Glycosphingolipids as emerging attack points in bladder cancer

  • Bladder cancer is a prevalent malignancy associated with significant morbidity and mortality worldwide. Emerging research highlights the critical role of glycosphingolipids (GSLs) in bladder cancer progression. In this review, we examine GSL expression profiles in bladder cancer and explore their contributions to key cancer hallmarks, including invasion and metastasis, immune evasion, and resistance to cell death. We further discuss the potential of GSLs as therapeutic targets and non-invasive biomarkers, with an emphasis on recent advances in GSL-targeting strategies. Additionally, we highlight our recent discovery of a novel, patented biomarker for bladder cancer diagnosis, identified using cutting-edge glyco-analytical technologies.

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Inês B. Moreira, Falk F. R. BuettnerORCiDGND
URN:urn:nbn:de:bvb:384-opus4-1216096
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/121609
ISSN:2730-6011OPAC
Parent Title (English):Discover Oncology
Publisher:Springer Science and Business Media LLC
Type:Article
Language:English
Year of first Publication:2025
Publishing Institution:Universität Augsburg
Release Date:2025/05/07
Volume:16
Issue:1
First Page:569
DOI:https://doi.org/10.1007/s12672-025-02302-y
Institutes:Medizinische Fakultät
Medizinische Fakultät / Professur für Proteinanalytik
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):CC-BY 4.0: Creative Commons: Namensnennung (mit Print on Demand)